secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0000950170-23-049433
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Laboratories enters ATM equity distribution agreement for up to $3.25M
--------------------------------------------------------------------------------

- Agreement with Maxim Group LLC to sell up to $3.25M of common stock in at-the-market offerings.
- Commission of 3.0% of gross sales price plus up to $35,000 legal fee reimbursement.
- Offering subject to SEC effectiveness of S-3 registration statement filed September 18, 2023.
- No shares have been sold yet; sales will occur from time to time at prevailing market prices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023049433/0000950170-23-049433-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017023049433/hscs-20230918.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-049433

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer